COMPARISON OF THE EFFICACY OF 10 DAY-TRIPLE THERAPY-BASED, BISMUTH- CONTAINING QUADRUPLE THERAPY WITH TRIPLE THERAPY FOR THE FIRST LINE THERAPY OF HELICOBACTER PYLORI

被引：0
作者：
Moon, B. S. [1 ]
Yi, S. W. [1 ]
Lim, H. C. [1 ]
Lee, Y. C. [2 ]
机构：
[1] Yonsei Univ, Yongin Severance Hosp, Seoul 120749, South Korea
[2] Yonsei Univ, Severance Hosp, Seoul 120749, South Korea
来源：
HELICOBACTER | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.10
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF AOC AND AOM TRIPLE, SEQUENTIAL, AND CONCOMITANT THERAPY AS THE FIRST LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI
    Kim, Jin Il
    GASTROENTEROLOGY, 2017, 152 (05) : S249 - S249
  • [42] Comparison of AOC and AOM triple, sequential, and concomitant therapy as the first line eradication therapy for Helicobacter pylori
    Shin, S.
    Cheung, D. Y.
    HELICOBACTER, 2017, 22
  • [43] 10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection
    Campillo, Ana
    Amorena, Edurne
    Ostiz, Miriam
    Kutz, Marcos
    Lalglesia, Matilde
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (09): : 584 - 589
  • [44] Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
    Ji Young Chang
    Ki-Nam Shim
    Chung Hyun Tae
    Ko Eun Lee
    Jihyun Lee
    Kang Hoon Lee
    Chang Mo Moon
    Seong-Eun Kim
    Hye-Kyung Jung
    Sung-Ae Jung
    BMC Gastroenterology, 17
  • [45] Triple therapy versus concomitant therapy for the first-line Helicobacter pylori eradication
    Lee, M.
    Kim, G.
    Lee, B.
    Jeon, H.
    Park, E.
    Song, G.
    HELICOBACTER, 2017, 22
  • [46] Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
    Chang, Ji Young
    Shim, Ki-Nam
    Tae, Chung Hyun
    Lee, Ko Eun
    Lee, Jihyun
    Lee, Kang Hoon
    Moon, Chang Mo
    Kim, Seong-Eun
    Jung, Hye-Kyung
    Jung, Sung-Ae
    BMC GASTROENTEROLOGY, 2017, 17
  • [47] Bismuth-based quadruple therapy for Helicobacter pylori -: a single triple capsule plus lansoprazole
    de Boer, WA
    Van Etten, RJXM
    Van de Wouw, BAM
    Schneeberger, PM
    Van Oijen, AHAM
    Jansen, JBMJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (01) : 85 - 89
  • [48] Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
    Gisbert, J. P.
    Romano, M.
    Gravina, A. G.
    Solis-Munoz, P.
    Bermejo, F.
    Molina-Infante, J.
    Castro-Fernandez, M.
    Ortuno, J.
    Lucendo, A. J.
    Herranz, M.
    Modolell, I.
    del Castillo, F.
    Gomez, J.
    Barrio, J.
    Velayos, B.
    Gomez, B.
    Dominguez, J. L.
    Miranda, A.
    Martorano, M.
    Algaba, A.
    Pabon, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Federico, A.
    Marin, A. C.
    McNicholl, A. G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 768 - 775
  • [49] RIFABUTIN CONTAINING TRIPLE THERAPY VS. RIFABUTIN AND BISMUTH-CONTAINING QUADRUPLE THERAPY FOR THIRD-LINE TREATMENT OF HELICOBACTER PYLORI (H. PYLORI) INFECTION
    Tavani, R.
    Ciccaglione, A. F.
    Cellini, L.
    Grossi, L.
    Di Tullio, A. M.
    Pagliaro, M.
    Cocciolillo, S.
    Sepe, A.
    Di Berardino, M.
    Marzio, L.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S111 - S111
  • [50] Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection
    Campillo, Ana
    Ostiz, Miriam
    Amorena, Edurne
    Kutz, Marcos
    La Iglesia, Matilde
    MEDICINA CLINICA, 2016, 147 (05): : 199 - 201
12345